ARCHIVES

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

This article is from The Cancer Letter archive.

Vol. 29 No. 21 | May 23, 2003

Download PDF Visit The Full Archive

Related Articles

House Passes Bill Giving FDA Authority Over Tobacco Products

April 10, 2009

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001

Construction Grants Exclude City of Hope

September 20, 1985

NCI to Suggest Changes In Cooperative Group Terms of Award At Chairman’s Meeting Next Week

November 18, 1988

NCI Awards $10 Million To States for Cervix Screening

September 27, 1974

SBIR Solicitation Issued

September 13, 1996